Page last updated: 2024-10-31

entinostat and Pulmonary Arterial Remodeling

entinostat has been researched along with Pulmonary Arterial Remodeling in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Inhibition of HDAC1 alleviates pulmonary arterial remodeling and PAH through up-regulation of miR-34a level and subsequent reduction of MMP-9/TIMP-1 and MMP-2/TIMP-2, suggesting that inhibition of HDAC1 might have potential value in the management of PAH."5.62Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a. ( Chen, L; Li, F; Sun, X; Wan, Y; Wang, D; Wang, H, 2021)
"Inhibition of HDAC1 alleviates pulmonary arterial remodeling and PAH through up-regulation of miR-34a level and subsequent reduction of MMP-9/TIMP-1 and MMP-2/TIMP-2, suggesting that inhibition of HDAC1 might have potential value in the management of PAH."1.62Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a. ( Chen, L; Li, F; Sun, X; Wan, Y; Wang, D; Wang, H, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, F1
Wang, D1
Wang, H1
Chen, L1
Sun, X1
Wan, Y1

Other Studies

1 other study available for entinostat and Pulmonary Arterial Remodeling

ArticleYear
Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.
    Respiratory research, 2021, Aug-31, Volume: 22, Issue:1

    Topics: Animals; Benzamides; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Male; MicroRNAs; Monocro

2021